Personalis, Inc. , a leader in advanced genomics for precision oncology, today announced Medicare coverage of its ultrasensitive NeXT Personal® test for surveillance of cancer recurrence in breast ...

According to the NCCN Guidelines for metastatic lung cancer, standard therapies remain valuable, but they are no longer sufficient on their own. This is why molecular profiling, targeted therapy, and ...

Pfizer Inc. ( PFE) Discusses Clinical Development Strategy for 4404 Bispecific Antibody in Oncology November 10, 2025 8:30 AM EST ...

Objective The left atrial stiffness index (LASI) has been proven to be a promising marker for assessing left atrial (LA) and ...

Chronic kidney disease or CKD, is a condition that builds over time, as a result of inappropriate kidney function. The ...

Over the past decade, several tumor-based predictors of cetuximab efficacy have been identified, yet most function as ...

Circ-EGFR was identified as a novel predictive biomarker for cetuximab efficacy in KRAS wild-type metastatic colorectal ...

Individual patients may have substantial differences in their eGFRcr and eGFRcys for estimating kidney function, which has prognostic implications.

Diabetes, kidney disease, and high blood pressure are interconnected, silently damaging vital organs and increasing the risk ...

Chronic kidney disease (CKD) is a slow health problem that affects how well your kidneys clean your blood. It has five stages ...